FindTrial
Sign In

Observation of Clinical Response and Nursing Care for Treatment of Cervical Cancer with Kadonlinib.

Observation of Clinical Response and Nursing Care for Treatment of Cervical Cancer with Kadonlinib.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118615
Enrollment
Unknown
Registered
2026-02-09
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

Observation group:Targeted intervention and care measures

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Diagnosed pathologically as cervical cancer; 2.Treated with cadonilimab; 3.Aged 18 years or older.

Exclusion criteria

Exclusion criteria: 1.Individuals with bleeding disorders or immune system impairments; 2.Those who are breastfeeding or pregnant; 3.Those who are known or suspected to be allergic to cadonilimab therapy.

Design outcomes

Primary

MeasureTime frame
Incidence of Adverse Reactions;—

Countries

China

Contacts

Public ContactLi Xiulan

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

632600374@qq.com+86 20 34070266

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026